Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021
About Assisted Reproductive Technology in Fertility Clinics
Infertility is a medical condition that affects both men and women. Generally, a couple is considered infertile when they are unable to conceive after a 12-month period of unprotected sexual intercourse. ART consists of a wide range of procedures that are used to treat infertility in men and women. These procedures are rendered to patients primarily in clinics, which treat infertility and are collectively referred to as fertility clinics.
Technavio’s analysts forecast the global assisted reproductive technology market in fertility clinics to grow at a CAGR of 4.36% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global assisted reproductive technology market in fertility clinics for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of ART solutions specifically to fertility clinics.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021
Technavio recognizes the following companies as the key players in the global assisted reproductive technology market in fertility clinics: CooperSurgical, EMD Serono, Ferring Pharmaceuticals, Irvine Scientific, and Vitrolife.
Other Prominent Vendors in the market are: Anecova, Cook Medical, CRITEX, Esco Micro, Genea, IHMedical, IKS International, INVO Bioscience, IVFtech, Kitazato, Pantec Biosolutions, and Smiths Medical.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of digital innovations. With the emergence of advanced technologies, which carry out various types of ART procedures, the market is evolving, and the change is evident in the way fertility clinics are marketing their services.”
According to the report, one driver in the market is growing awareness about ART procedures. There is a notable increase in the awareness about ART procedures among women compared with the last decade. This encouraged a positive attitude and acceptance among women worldwide. The increase in awareness can be attributed to several factors such as the rise in education level among the female population and the rise in the number of working women. This had a significant influence on the demand for various ART procedures, especially in developed and developing countries such as the US, the UK, and China.
Further, the report states that one challenge in the market is limited insurance coverage and improper regulatory oversight. Infertility treatment is considered as a lifestyle procedure rather than serious medicine. Health insurance plans commonly, but not always, pay for services related to testing for infertility. For instance, in the US, which does not have any infertility coverage mandate, most insurance policies do not cover fertility and IVF service payment. Some insurances cover testing and treatment up to and including intrauterine insemination but do not cover IVF. Also, at times, the monitoring of IVF ovarian stimulation (blood and ultrasound tests) is covered but IVF codes are not covered.
CooperSurgical, EMD Serono, Ferring Pharmaceuticals, Irvine Scientific, Vitrolife, Anecova, Cook Medical, CRITEX, Esco Micro, Genea, IHMedical, IKS International, INVO Bioscience, IVFtech, Kitazato, Pantec Biosolutions, and Smiths Medical.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook